Gsk Share Discussion Threads

[spud] 24/4/2020 14:43

Not bothered about price as I bought for income. Would prefer to see a progressive dividend policy tbh. spud

[robbiekeane] 24/4/2020 14:26

OK £17 next week, £18 next month and £25 by August everyone happy!!!

[tradermichael] 24/4/2020 09:22

Let's get through the Q1 results first! (Wed 29 April)

[cyfalafwr] 24/4/2020 08:50

Lets not get ahead of ourselves. Just hope to hit £18 in the next month.

[robbiekeane] 23/4/2020 16:45

Whatever is required to test / treat or beat covid will be signed off by the government. They are throwing money at drug companies to facilitate the search for a cure. GSK is doing it's bit by entering collaborations but hospital spend at the moment is waved through which will benefit pharma's.

[abdullla] 23/4/2020 14:54

NHS what blank cheque?

[robbiekeane] 23/4/2020 14:37

NHS Covid19 blank cheque could see this rise to £25 great defensive stock.

[aimtoretire] 17/4/2020 16:19

Since 24 Feb when the market started its dramatic downturn due to the coronavirus fallout, GSK has faired well IMO. It was around 16% down at its worst, whereas the FTSE 100 was around 32% down at its worst. GSK is now higher than it was immediately before the downturn, whereas the FTSE 100 is still well down.

[abdullla] 17/4/2020 16:07

Profit taking big time

[mister md] 17/4/2020 10:16

I didnt expect GSK to crash as much as the rest of the market last month, thought it would offer a bit of protection, especially since the crisis being of a 'medical' nature. Anyhow, seems to be recovering quite a bit now ...

[zho] 17/4/2020 09:20

Saxo are casting doubt on the Gilead story. "Something is fishy here".

[crossing_the_rubicon] 17/4/2020 09:15

Great news indeed.

"Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment"

Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment - This article by Adam Feuerstein for statnews.com may be of interest to subscribers.

A Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.

She added: “Most of our patients are severe and most of them are leaving at six days, so that tells us duration of therapy doesn’t have to be 10 days. We have very few that went out to 10 days, maybe three,” she said.

Remdesivir was one of the first medicines identified as having the potential to impact SARS-CoV-2, the novel coronavirus that causes Covid-19, in lab tests. The entire world has been waiting for results from Gilead’s clinical trials, and positive results would likely lead to fast approvals by the Food and Drug Administration and other regulatory agencies. If safe and effective, it could become the first approved treatment against the disease.

The University of Chicago Medicine recruited 125 people with Covid-19 into Gilead’s two Phase 3 clinical trials. Of those people, 113 had severe disease. All the patients have been treated with daily infusions of remdesivir. 

“The best news is that most of our patients have already been discharged, which is great. We’ve only had two patients perish,” said Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the remdesivir studies for the hospital.





Wonder why the Chinese have cancelled two such trials using Remdesivir?

[tradermichael] 17/4/2020 07:22

cyfalafwr - Nothing wrong with an 'unbalanced' portfolio if you buy the right one!

[watfordhornet] 16/4/2020 18:41

By far my biggest holding as well. Missed out on some of the recent rises such as oil but tend to feel this is a little safer and more stable.Won't see 20% daily rises but also bit more conservative in down times.

[cyfalafwr] 16/4/2020 18:36

A big chunk of my portfolio (30%) is in pharma i.e.GSK . Perhaps I should think of selling my other stocks and buy AZ etc . That would give me an unbalanced portfolio , but in these dark days logic goes out of the window.

[badtime] 16/4/2020 16:52

I lightened up in March oh deary me ..least I kept some

[essentialinvestor] 16/4/2020 15:38

chess, hindsight is great, eh!.

[abdullla] 16/4/2020 15:31

TM,well played buying GSK with your divi yesterday,good luck

[chessman2] 16/4/2020 15:17

How foolish of me. I recently decided to buy either GSK at 1500p or BT at 119p.

I already hold here from 1300p so went for BT.

GSK is certainly one to hold in the coming months and years.

[rikky72] 16/4/2020 11:44

AZ still considerably outperforming this, now only 3% off its year high compared to 14% for GSK. However, there are some encouraging signs here though.

[abdullla] 15/4/2020 18:19

Got it,thanks TM

[tradermichael] 15/4/2020 16:30

The guidance from Q4 (full year) was:
Expect Adjusted EPS to decline -1% to -4% CER
Expect 80p dividend for 2020

The market (as ever) overreacted at the time, then the virus did its bit.

[tradermichael] 15/4/2020 16:27

IN @ 1564.136 (£9.5K) …… ;0)

[aimtoretire] 15/4/2020 16:24

Well there was news in the press on 5 Feb about GSK warning that profits are to fall as they step up their R&D spending -